elranatamab
pfizer
['elranatamab', 'mmsm']
optimized dosing to mitigate crs with elrantamab in myeloma. #ash22 #mmsm 
Professor of Medicine, Chief of Myeloma Division & Experimental Therapeutics Program. Sylvester Comprehensive Cancer Center, University of Miami. Tweets = mine